Cysteine biosynthesis through the sulfate assimilation pathway, which involves the transport of inorganic sulfate into the cell, could be disrupted in cancers with increased amounts of SM4, because the sulfur redistribution shifts toward conversion to PAPS (as mentioned earlier, PAPS serves as a donor for sulfotransferases like CST). The gene discussed is GAL3ST1; the disease is cancer.